{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T08:17:55Z","timestamp":1777969075182,"version":"3.51.4"},"reference-count":32,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15557","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T12:02:09Z","timestamp":1774872129000},"page":"1-10","source":"Crossref","is-referenced-by-count":0,"title":["Immune\u2011imaging biomarkers: Prognostic value of splenic volume and circulating lymphocytes in upper tract urothelial carcinoma"],"prefix":"10.3892","volume":"31","author":[{"given":"Chien-Hsiung","family":"Lo","sequence":"first","affiliation":[{"name":"Department of Urology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 70403, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun-Che","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Urology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 70403, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chu-An","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan 70401, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Che-Yuan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Urology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 70403, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Hui","family":"Ou","sequence":"additional","affiliation":[{"name":"Department of Urology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 70403, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hau-Chern","family":"Jan","sequence":"additional","affiliation":[{"name":"Department of Urology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 70403, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"key20260505102909_b1-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","article-title":"Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973\u20132005","volume":"107","author":"Raman","year":"2011","journal-title":"BJU Int"},{"key":"key20260505102909_b2-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1111\/j.1464-410X.2009.08838.x","article-title":"Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract","volume":"104","author":"Colin","year":"2009","journal-title":"BJU Int"},{"key":"key20260505102909_b3-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","article-title":"European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2020 update","volume":"79","author":"Roupr\u00eat","year":"2021","journal-title":"Eur Urol"},{"key":"key20260505102909_b4-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"446","DOI":"10.6004\/jnccn.2013.0059","article-title":"Bladder cancer","volume":"11","author":"Clark","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"key":"key20260505102909_b5-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.eururo.2010.12.042","article-title":"European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update","volume":"59","author":"Roupr\u00eat","year":"2011","journal-title":"Eur Urol"},{"key":"key20260505102909_b6-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","article-title":"European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2023 update","volume":"84","author":"Roupr\u00eat","year":"2023","journal-title":"Eur Urol"},{"key":"key20260505102909_b7-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.3390\/cancers14194841","article-title":"Neoadjuvant chemotherapy before nephroureterectomy in high-risk upper tract urothelial cancer: A systematic review and meta-analysis","volume":"14","author":"Oswald","year":"2022","journal-title":"Cancers (Basel)"},{"key":"key20260505102909_b8-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1080\/14737140.2023.2265572","article-title":"Immunotherapy in urothelial cancer: Current status and future directions","volume":"23","author":"Piombino","year":"2023","journal-title":"Expert Rev Anticancer Ther"},{"key":"key20260505102909_b9-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): A phase 3, open-label, randomised controlled trial","volume":"395","author":"Birtle","year":"2020","journal-title":"Lancet"},{"key":"key20260505102909_b10-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"e484","DOI":"10.1016\/j.clgc.2019.12.008","article-title":"Combination of Platelet-lymphocyte ratio and Monocyte-lymphocyte ratio as a new promising prognostic factor in upper tract urothelial carcinoma with large Tumor Sizes >3 cm","volume":"18","author":"Jan","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"key20260505102909_b11-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cca.2019.02.007","article-title":"Predictive value of preoperative lymphocyte-to-monocyte ratio for patients with upper tract urothelial carcinoma","volume":"492","author":"Li","year":"2019","journal-title":"Clin Chim Acta"},{"key":"key20260505102909_b12-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s00345-018-2235-5","article-title":"Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients","volume":"36","author":"Vartolomei","year":"2018","journal-title":"World J Urol"},{"key":"key20260505102909_b13-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1245\/s10434-019-07167-4","article-title":"Combination of the preoperative systemic Immune-inflammation index and Monocyte-lymphocyte ratio as a novel prognostic factor in patients with Upper-tract urothelial carcinoma","volume":"26","author":"Jan","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"key20260505102909_b14-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1158\/0008-5472.CAN-20-2339","article-title":"Splenic hematopoietic and stromal cells in cancer progressionthe spleen in cancer progression","volume":"81","author":"Steenbrugge","year":"2021","journal-title":"Cancer Res"},{"key":"key20260505102909_b15-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nri1669","article-title":"Structure and function of the spleen","volume":"5","author":"Mebius","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"key20260505102909_b16-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s00330-020-07313-7","article-title":"Association between spleen volume and the post-hepatectomy liver failure and overall survival of patients with hepatocellular carcinoma after resection","volume":"31","author":"Bae","year":"2021","journal-title":"Eur Radiol"},{"key":"key20260505102909_b17-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"1065716","DOI":"10.3389\/fonc.2022.1065716","article-title":"Baseline splenic volume as a biomarker for clinical outcome and circulating lymphocyte count in gastric cancer","volume":"12","author":"Zeng","year":"2023","journal-title":"Front Oncol"},{"key":"key20260505102909_b18-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.3390\/cancers13123020","article-title":"Splenic volume as a surrogate marker of immune checkpoint inhibitor efficacy in metastatic non small cell lung cancer","volume":"13","author":"Galland","year":"2021","journal-title":"Cancers"},{"key":"key20260505102909_b19-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1073\/pnas.1113744109","article-title":"Origins of tumor-associated macrophages and neutrophils","volume":"109","author":"Cortez-Retamozo","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20260505102909_b20-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3390\/cancers12061429","article-title":"Baseline splenic volume as a prognostic biomarker of FOLFIRI efficacy and a surrogate marker of MDSC accumulation in metastatic colorectal carcinoma","volume":"12","author":"Niogret","year":"2020","journal-title":"Cancers (Basel)"},{"key":"key20260505102909_b21-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.3390\/cancers14153574","article-title":"Baseline splenic volume outweighs Immuno-modulated size changes with regard to survival outcome in patients with hepatocellular carcinoma under immunotherapy","volume":"14","author":"M\u00fcller","year":"2022","journal-title":"Cancers (Basel)"},{"key":"key20260505102909_b22-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A guideline of selecting and reporting intraclass correlation coefficients for reliability research","volume":"15","author":"Koo","year":"2016","journal-title":"J Chiropr Med"},{"key":"key20260505102909_b23-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00262-016-1953-z","article-title":"Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients","volume":"66","author":"Jordan","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"key20260505102909_b24-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"25617","DOI":"10.18632\/oncotarget.25424","article-title":"Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinoma","volume":"9","author":"Aarnink","year":"2018","journal-title":"Oncotarget"},{"key":"key20260505102909_b25-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.celrep.2012.08.006","article-title":"Immune tolerance to tumor antigens occurs in a specialized environment of the spleen","volume":"2","author":"Ugel","year":"2012","journal-title":"Cell Rep"},{"key":"key20260505102909_b26-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.cell.2020.02.036","article-title":"Tumor-induced generation of splenic Erythroblast-like Ter-cells promotes tumor progression","volume":"184","author":"Han","year":"2021","journal-title":"Cell"},{"key":"key20260505102909_b27-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/s41591-018-0205-5","article-title":"Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells","volume":"24","author":"Zhao","year":"2018","journal-title":"Nat Med"},{"key":"key20260505102909_b28-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1158\/1541-7786.MCR-20-0746","article-title":"Multiorgan signaling mobilizes Tumor-associated erythroid cells expressing immune checkpoint molecules","volume":"19","author":"Sano","year":"2021","journal-title":"Mol Cancer Res"},{"key":"key20260505102909_b29-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1172\/JCI97973","article-title":"Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis","volume":"128","author":"Wu","year":"2018","journal-title":"J Clin Invest"},{"key":"key20260505102909_b30-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1002\/eji.202048666","article-title":"Human splenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are strategically located immune regulatory cells in cancer","volume":"50","author":"Tavukcuoglu","year":"2020","journal-title":"Eur J Immunol"},{"key":"key20260505102909_b31-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3892\/ol.2021.12886","article-title":"Association between cellular immune response and spleen weight in mice with hepatocellular carcinoma","volume":"22","author":"Jiang","year":"2021","journal-title":"Oncol Lett"},{"key":"key20260505102909_b32-ol-31-5-15557","doi-asserted-by":"publisher","first-page":"e998469","DOI":"10.1080\/2162402X.2014.998469","article-title":"Splenectomy inhibits non-small cell lung cancer growth by modulating anti-tumor adaptive and innate immune response","volume":"4","author":"Levy","year":"2015","journal-title":"Oncoimmunology"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:29:14Z","timestamp":1777966154000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3,30]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15557","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]}}}